Loading organizations...
§ Private Profile · Taizhou, China
Tongxuan Medical is a technology company.
Tongxuan Medical develops and manufactures advanced balloon dilatation catheters for various medical applications. The company focuses on interventional medical devices, particularly those used in prostatic conditions, providing specialized solutions for clinical needs. Its approach centers on device research and development to enhance minimally invasive treatment options within the medical industry.
Established in 2020, Tongxuan Medical originated from an understanding of the demand for sophisticated interventional tools within the Chinese medical landscape. The company’s foundation aimed to address specific gaps in available treatment technologies, channeling expertise into creating specialized devices. This establishment was built to contribute to the evolution of medical procedures.
The company's products serve medical professionals and healthcare institutions primarily within the Chinese market, equipping them with tools for precise therapeutic interventions. Tongxuan Medical's long-term vision is to advance patient care by continually innovating its portfolio of interventional devices, striving for improved clinical outcomes and expanding access to modern medical technologies.
Tongxuan Medical has raised $42.0M across 1 funding round.
Tongxuan Medical has raised $42.0M in total across 1 funding round.
Tongxuan Medical is a technology company specializing in the development of innovative balloon catheter medical devices primarily used in cardiovascular treatments. It serves healthcare providers by offering advanced medical tools designed to improve the safety and efficacy of procedures such as coronary artery interventions. The company addresses critical clinical challenges related to blood vessel blockages and blood spot removal, contributing to better patient outcomes. Since its founding in 2020, Tongxuan Medical has demonstrated growth momentum through patent filings and product innovation in the medical device sector[2][4][5].
Founded in 2020, Tongxuan Medical originated with a focus on leveraging cutting-edge technology to enhance cardiovascular medical devices. The founding team brought expertise in medical technology development, which helped the company quickly establish itself in the competitive medical device market. Early traction included securing patents for balloon catheters capable of removing blood spots in coronary arteries, a pivotal innovation that underscored its commitment to addressing unmet clinical needs[4][5].
Tongxuan Medical operates at the intersection of medical technology innovation and cardiovascular healthcare, riding the global trend toward minimally invasive and precision medical devices. The timing is favorable due to increasing cardiovascular disease prevalence and growing demand for advanced interventional tools. Market forces such as aging populations and healthcare modernization support the adoption of innovative catheter technologies. Tongxuan Medical contributes to the broader ecosystem by pushing forward device innovation that can be integrated into clinical practice, potentially influencing standards in cardiovascular treatment[2][5].
Looking ahead, Tongxuan Medical is positioned to expand its product portfolio and deepen its impact in cardiovascular device markets. Trends such as digital health integration, personalized medicine, and minimally invasive procedures will likely shape its development trajectory. As it continues to innovate and secure regulatory approvals, Tongxuan Medical’s influence in the medical device sector is expected to grow, potentially leading to broader adoption of its technologies and partnerships with global healthcare providers.
This trajectory ties back to its founding mission of leveraging technology to solve critical cardiovascular challenges, marking Tongxuan Medical as a notable player in advancing medical device innovation.
Tongxuan Medical has raised $42.0M in total across 1 funding round.
Tongxuan Medical's investors include Qiming Venture Partners.
Tongxuan Medical has raised $42.0M across 1 funding round. Most recently, it raised $42.0M Series B in August 2025.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Aug 1, 2025 | $42M Series B | — | Qiming Venture Partners | Announced |